mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
BRD-K35604418 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
-0.16 |
0.003 |
mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
-0.099 |
0.003 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
BRD-K37390332 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.005 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.005 |
mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |